Signify Premium Insight: Is Patent 99 the Key to Increasing Volpara’s ARPU?
Published: March 17, 2022
Breast imaging software vendor Volpara Health recently announced that it was awarded a US patent for a new method of the detection and quantification of breast arterial calcifications (BACs), taking Volpara’s total number of patents to 99.
The detection of breast arterial calcification is usually considered as benign and merely an incidental finding from an oncological perspective. However, with elevated levels of calcification associated with a range of conditions, including coronary artery disease, strokes, hypertension, chronic kidney disease and others, Volpara believes that offering an AI-based tool, which can detect and quantify BACs during routine mammographic screening, can ultimately improve patient outcomes. The vendor acknowledges that a commercial product for use in routine screening is still some way off, but the latest patent, which identifies BACs from a mammogram,